Jordan Pharmaceuticals and Healthcare Report Q3 2009

Publication Date	June 2009
Publisher	Business Monitor
Product Type	Report
Pages	80
ISBN Number	1748-1988
Product Code	BMI03405

Buy this product or for assistance call +44 20 7060 7474

PDF £250.00$416 | €280

FAX Order above formats by FAX

Summary

BMI has revised its extended forecast for Jordan's pharmaceutical and healthcare market for our Q309 report. We expect the total drug market to grow from US$370mn in 2008 to US$519mn by 2013, representing a compound annual growth rate (CAGR) of 7.01%. The main drivers for growth include the continuing high volume medicine export activity, generated by Jordan's domestic drug manufacturers.

Additionally, the epidemiological profile of Jordan indicates an increasing burden of obesity and diabetes-related disorders, which will drive spending in overall healthcare.

According to the Jordanian Association of Pharmaceutical Manufactures (JAPM) drug exports in 2007 reached JOD460mn (US$647mn), rising to JOD500mn (US$704mn) by 2008; however, it also revealed that the global economic downturn will reduce demand for Jordanian medicines. BMI's forecast indicates drug exports will rise in Jordan from a more moderate US$531mn in 2008 to US$1.32bn by 2013, representing a 20.0% CAGR. In line with the JAPM, we agree that the Jordanian pharmaceutical export industry is unlikely to reach its 2011 JOD1bn target.

Jordan is the most popular destination for medical tourists within the Arab world and this sector has been steadily growing since 2006. The country's relatively cheap and high quality health services have been attracting patients from other Middle Eastern and North African countries including Yemen, Algeria, Iraq, Palestine and Sudan. We believe that boosting investment in this sector can open new markets with tourists from the US and Europe seeking lower cost medical procedures.

In February 2009 Jordan held an international medical tourism congress with representatives from the Private Hospital Association (PHA) and the US Agency for International Development (USAID). The meeting aimed to develop new strategies to improve and expand the capacity of the private health sector while also seeking opportunities for growth from other markets. Regulatory policies are also being implemented to gain international quality accreditation to provide standardised protocols for global patients.

Jordan's current medical tourism sector revenues are estimated to reach US$650mn by the end of 2009 and the country is keen to reach its ambitious target of US$1bn by 2012. We believe this is unlikely in light of the early stages of US and international interest and therefore expect a more modest outcome by this date. The Middle Eastern country has a relatively stable political environment with highly-qualified Arab doctors. In addition, its good relations with other neighbouring nations have ensured a sizable Arab patient interest for Jordanian medical expertise, in addition to an excellent reputation. According to details from a health tourism conference in Jordan during 2007, the private sector had 33.6% of the total hospital beds in the country, compared to 38.3% for the Ministry of Health-funded sector. In-patients contributed to over 70% of total private care costs, suggesting that invasive procedures that are expensive in other regions, including cardiovascular, joint replacements and cosmetic or corrective surgery, are the main reasons for choosing Jordanian healthcare services.

Content

Executive Summary
SWOT Analysis
Jordan Pharmaceuticals And Healthcare Industry SWOT
Jordan Political SWOT
Jordan Economic SWOT
Jordan Business Environment Industry SWOT
Pharmaceutical Business Environment Ratings
Limits To Potential Returns
Risks To Realisation Of Returns
Market Summary
Regulatory Regime
Intellectual Property Developments
Counterfeit Pharmaceuticals
Pricing And Reimbursement Issues
International Collaboration
Industry Developments
Epidemiology
Healthcare Sector
Recent Healthcare Sector Developments
Medical Tourism
Domestic Pharmaceuticals Sector
Recent Domestic Company Activities
Foreign Companies
Retail Pharmacy Sector
Research And Development Sector
Clinical Trials
Medical Devices
Industry Forecast Scenario
Overall Market Forecasts
Key Growth Factors - Industry
Macroeconomic Forecast
Prescription Drug Market Forecast
OTC Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
Medical Device Market Forecast
Import/Export Forecasts
Other Healthcare Data Forecasts
Key Risks To BMI's Forecasts
Competitive Landscape
Company Profiles
Multinational Companies
Novartis
Sanofi-Aventis
Pfizer
GlaxoSmithKline
Merck & Co
Indigenous Manufacturers
Pharma International Company
Arab Pharmaceutical Manufacturers (APM)
Dar Al Dawa (DAD)
Hikma Pharmaceuticals
Jordanian Pharmaceutical Manufacturing (JPM)
United Pharmaceutical Manufacturers
Arab Pharmaceutical Manufacturers (APM)...........................................................................................................Error! Bookmark not defined.
Dar Al Dawa (DAD) ...............................................................................................................................................Error! Bookmark not defined.
Hikma Pharmaceuticals..........................................................................................................................................Error! Bookmark not defined.
Jordanian Pharmaceutical Manufacturing (JPM)...................................................................................................Error! Bookmark not defined.
Country Snapshot: Jordan Demographic Data
Section 1: Population
Section 2: Education And Healthcare
Section 3: Labour Market And Spending Power
BMI Forecast Modelling
How We Generate Our Pharmaceutical Industry Forecasts
Pharmaceutical Business Environment Ratings Methodology
Ratings Overview
Weighting
Sources
List of Tables
- Table: Regional Pharma Business Environment Ratings Q209
- Table: Jordan - Drug Market Expenditure Indicators, 2004-2013
- Table: Jordan - Healthcare Expenditure Indicators, 2004-2013
- Table: Jordan - Economic Activity
- Table: Jordan - Prescription Market Indicators, 2004-2013 (US$mn unless otherwise stated)
- Table: Jordan - OTC Market Indicators, 2004-2013 (US$mn unless otherwise stated)
- Table: Jordan - Patented Drugs Market Indicators, 2004-2013
- Table: Jordan - Generics Market Indicators, 2004-2013
- Table: Jordan Medical Device Market 2004-2013
- Table: Jordan - Pharmaceutical Trade Indicators, 2004-2013 (US$mn)
- Table: Other Healthcare Indicators, 2004-2013
- Table: Top Six Drugmakers In Jordan, H107
- Table: Demographic Indicators, 2005-2030
- Table: Rural/Urban Breakdown, 2005-2030
- Table: Education, 2002-2005
- Table: Vital Statistics, 2005-2030
- Table: Consumer Expenditure, 2000-2012
- Table: Average Annual Manufacturing Wages, 2000-2012
- Table: Pharmaceutical Business Environment Indicators
- Table: Weighting Of Components

Delivery Details

PDF:Immediate delivery

Ask a question about this product

Need help finding the right product?

Product features / use

Level	General Industry Strategies
Data	Detailed Market Forecasts
Profiles	Profiles of Key Companies
Features	Contains SWOT Analysis
Extra Info	Consumer Trends Highlighted